The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1199
January 3, 2005
View Complete Issue         Table of Contents 2019 
Antiviral KLEENEX
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Antiviral KLEENEX
January 3, 2005 (Issue: 1199)
The first commercially available virucidal tissue, KLEENEX Anti-Viral Tissue (Kimberly-Clark), was recently introduced and is being heavily promoted to the general public. Patients may ask healthcare providers about the usefulness of these products....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Antiviral KLEENEX
Article code: 1199b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.